OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against Streptococci
Jiqing Ye, Xiao Yang, Cong Ma
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4085-4085
Open Access | Times Cited: 6
Jiqing Ye, Xiao Yang, Cong Ma
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4085-4085
Open Access | Times Cited: 6
Showing 6 citing articles:
Ligand-Based Drug Design of Novel Antimicrobials against Staphylococcus aureus by Targeting Bacterial Transcription
Jiqing Ye, Xiao Yang, Cong Ma
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 339-339
Open Access | Times Cited: 16
Jiqing Ye, Xiao Yang, Cong Ma
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 339-339
Open Access | Times Cited: 16
Inhibition of bacterial RNA polymerase function and protein–protein interactions: a promising approach for next-generation antibacterial therapeutics
Jiqing Ye, Cheuk Hei Kan, Xiao Yang, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1471-1487
Closed Access | Times Cited: 3
Jiqing Ye, Cheuk Hei Kan, Xiao Yang, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1471-1487
Closed Access | Times Cited: 3
Sulfonamidyl derivatives of sigmacidin: Protein-protein interaction inhibitors targeting bacterial RNA polymerase and sigma factor interaction exhibiting antimicrobial activity against antibiotic-resistant bacteria
Jiqing Ye, Cheuk Hei Kan, Yingbo Zheng, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106983-106983
Closed Access | Times Cited: 4
Jiqing Ye, Cheuk Hei Kan, Yingbo Zheng, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106983-106983
Closed Access | Times Cited: 4
Discovery of Inhibitors Targeting Protein–Protein Interaction between Bacterial RNA Polymerase and NusG as Novel Antimicrobials
Yingbo Zheng, Cheuk Hei Kan, Tsz Fung Tsang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16556-16575
Closed Access
Yingbo Zheng, Cheuk Hei Kan, Tsz Fung Tsang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16556-16575
Closed Access
Frontiers in New Drug Discovery: From Molecular Targets to Preclinical Trials
Dmitry L. Aminin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8321-8321
Open Access
Dmitry L. Aminin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8321-8321
Open Access
FOMO: A Fragment-based Objective Molecule Optimization Framework
Cong Ma, Zeqi Zhang, Min Xu, et al.
Research Square (Research Square) (2023)
Open Access
Cong Ma, Zeqi Zhang, Min Xu, et al.
Research Square (Research Square) (2023)
Open Access
